122 related articles for article (PubMed ID: 37493576)
1. SPLENIC INVARIANT NATURAL KILLER T CELLS PLAY A SIGNIFICANT ROLE IN THE RESPONSE TO POLYMICROBIAL SEPSIS.
Heffernan DS; Chung CS; Ayala A
Shock; 2023 Sep; 60(3):443-449. PubMed ID: 37493576
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-30 (IL27p28) alleviates experimental sepsis by modulating cytokine profile in NKT cells.
Yan J; Mitra A; Hu J; Cutrera JJ; Xia X; Doetschman T; Gagea M; Mishra L; Li S
J Hepatol; 2016 May; 64(5):1128-1136. PubMed ID: 26767500
[TBL] [Abstract][Full Text] [Related]
3. Galectin-9 prolongs the survival of septic mice by expanding Tim-3-expressing natural killer T cells and PDCA-1+ CD11c+ macrophages.
Kadowaki T; Morishita A; Niki T; Hara J; Sato M; Tani J; Miyoshi H; Yoneyama H; Masaki T; Hattori T; Matsukawa A; Hirashima M
Crit Care; 2013 Dec; 17(6):R284. PubMed ID: 24321251
[TBL] [Abstract][Full Text] [Related]
4. IL-15 Superagonist Expands mCD8+ T, NK and NKT Cells after Burn Injury but Fails to Improve Outcome during Burn Wound Infection.
Patil NK; Luan L; Bohannon JK; Guo Y; Hernandez A; Fensterheim B; Sherwood ER
PLoS One; 2016; 11(2):e0148452. PubMed ID: 26859674
[TBL] [Abstract][Full Text] [Related]
5. Anti-PD-L1 peptide improves survival in sepsis.
Shindo Y; McDonough JS; Chang KC; Ramachandra M; Sasikumar PG; Hotchkiss RS
J Surg Res; 2017 Feb; 208():33-39. PubMed ID: 27993215
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E-mediated immune regulation in sepsis.
Kattan OM; Kasravi FB; Elford EL; Schell MT; Harris HW
J Immunol; 2008 Jul; 181(2):1399-408. PubMed ID: 18606694
[TBL] [Abstract][Full Text] [Related]
7. Program Cell Death Receptor-1-Mediated Invariant Natural Killer T-Cell Control of Peritoneal Macrophage Modulates Survival in Neonatal Sepsis.
Fallon EA; Chun TT; Young WA; Gray C; Ayala A; Heffernan DS
Front Immunol; 2017; 8():1469. PubMed ID: 29209308
[TBL] [Abstract][Full Text] [Related]
8. The role of hepatic invariant NKT cells in systemic/local inflammation and mortality during polymicrobial septic shock.
Hu CK; Venet F; Heffernan DS; Wang YL; Horner B; Huang X; Chung CS; Gregory SH; Ayala A
J Immunol; 2009 Feb; 182(4):2467-75. PubMed ID: 19201902
[TBL] [Abstract][Full Text] [Related]
9. Evolution of an immune suppressive macrophage phenotype as a product of P38 MAPK activation in polymicrobial sepsis.
Song GY; Chung CS; Jarrar D; Chaudry IH; Ayala A
Shock; 2001 Jan; 15(1):42-8. PubMed ID: 11198356
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of CD1d activation suppresses septic mortality: a role for NK-T cells in septic immune dysfunction.
Rhee RJ; Carlton S; Lomas JL; Lane C; Brossay L; Cioffi WG; Ayala A
J Surg Res; 2003 Nov; 115(1):74-81. PubMed ID: 14572776
[TBL] [Abstract][Full Text] [Related]
11. invariant Natural Killer T Cells Modulate the Peritoneal Macrophage Response to Polymicrobial Sepsis.
Heffernan DS; Chun TT; Monaghan SF; Chung CS; Ayala A
J Surg Res; 2024 Jun; 300():211-220. PubMed ID: 38824851
[TBL] [Abstract][Full Text] [Related]
12. Differential alterations of tissue T-cell subsets after sepsis.
Sharma A; Yang WL; Matsuo S; Wang P
Immunol Lett; 2015 Nov; 168(1):41-50. PubMed ID: 26362089
[TBL] [Abstract][Full Text] [Related]
13. Effect of PD-1: PD-L1 in Invariant Natural Killer T-Cell Emigration and Chemotaxis Following Sepsis.
Young JS; Heffernan DS; Chung CS; Kettenmann ML; Young WA; Guillen VS; Cioffi WG; Ayala A
Shock; 2016 May; 45(5):534-9. PubMed ID: 26717105
[TBL] [Abstract][Full Text] [Related]
14. NK1.1
An JN; Ryu S; Kim YC; Yoo KD; Lee J; Kim HY; Lee H; Lee JP; Lee JW; Jeon US; Kim DK; Kim YS; Yang SH
Am J Physiol Renal Physiol; 2021 May; 320(5):F772-F788. PubMed ID: 33719574
[TBL] [Abstract][Full Text] [Related]
15. NKT cell exacerbation of liver metastases arising from melanomas transplanted into either the eyes or spleens of mice.
Yang W; Li H; Mayhew E; Mellon J; Chen PW; Niederkorn JY
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3094-102. PubMed ID: 21330669
[TBL] [Abstract][Full Text] [Related]
16. T helper type 2-polarized invariant natural killer T cells reduce disease severity in acute intra-abdominal sepsis.
Anantha RV; Mazzuca DM; Xu SX; Porcelli SA; Fraser DD; Martin CM; Welch I; Mele T; Haeryfar SM; McCormick JK
Clin Exp Immunol; 2014 Nov; 178(2):292-309. PubMed ID: 24965554
[TBL] [Abstract][Full Text] [Related]
17. A novel role for programmed cell death receptor ligand 2 in sepsis-induced hepatic dysfunction.
Rossi AL; Le M; Chung CS; Chen Y; Fallon EA; Matoso A; Xu S; Chun TT; Erickson CP; Ayala A
Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G106-G114. PubMed ID: 30431333
[TBL] [Abstract][Full Text] [Related]
18. Killing efficiency affected by mutually modulated PD-1 and PD-L1 expression via NKT-hepatoma cell interactions.
Liu L; Yang M; Xu Q; Zhou M; Cheng Y; Xu H; Qin Y; Liu B
Immunotherapy; 2021 Feb; 13(2):113-123. PubMed ID: 33076728
[No Abstract] [Full Text] [Related]
19. PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication.
Wang XF; Lei Y; Chen M; Chen CB; Ren H; Shi TD
J Viral Hepat; 2013 Apr; 20 Suppl 1():27-39. PubMed ID: 23458522
[TBL] [Abstract][Full Text] [Related]
20. Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regression.
Nelson A; Gebremeskel S; Lichty BD; Johnston B
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35246474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
